Related Experiment Video
Updated: Jun 14, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
An observational study of type 2 diabetes within a large Australian tertiary hospital pediatric diabetes service
Sandra D Ruhayel1, Rebecca A James, Sarah Ehtisham
1Department of Endocrinology and Diabetes at the Royal Children's Hospital, Parkville, Victoria, Australia.
Insights
Type 2 diabetes mellitus (T2DM) in youth is a growing concern. This study found that young T2DM patients have significant comorbidities like dyslipidemia and hypertension, posing challenges for management.
Area of Science:
- Pediatric Endocrinology
- Metabolic Disorders
- Public Health
Background:
- Type 2 diabetes mellitus (T2DM) is increasingly prevalent in children and adolescents.
- This demographic shift presents unique clinical challenges.
- Understanding the characteristics of pediatric T2DM is crucial for effective healthcare strategies.
Purpose of the Study:
- To identify pediatric patients diagnosed with T2DM within a large tertiary hospital's diabetes service.
- To investigate the clinical course and management aspects of T2DM in this young population.
- To assess the burden of T2DM on specialized diabetes services.
Main Methods:
- An initial 6-year audit of the diabetes service was conducted.
- A subsequent 2-year prospective case ascertainment period identified T2DM patients.
- Comprehensive data collection was performed on identified individuals.
Main Results:
- 33 pediatric patients with T2DM were identified out of 1574 total patients.
- High rates of comorbidities were observed: dyslipidemia (56%), microalbuminuria (45%), hypertension (30%), and retinopathy (25%).
- Hypertension correlated with higher BMI, while retinopathy was associated with elevated HbA1c levels. 27% were lost to follow-up.
Conclusions:
- Pediatric T2DM currently represents a low burden on the studied diabetes service.
- Patients diagnosed with T2DM in youth experience significant health complications.
- Developing effective management strategies for pediatric T2DM is a major challenge.
Background:
Type 2 diabetes mellitus (T2DM) is emerging as a significant clinical problem within the pediatric population.
Objective:
The objective of this study was to identify patients with T2DM in a large tertiary hospital diabetes service and examine aspects relating to clinical course and management.
Methods:
An initial audit of our diabetes service (over 6 yr) was followed by a 2-yr period of prospective case ascertainment to identify patients with T2DM. Comprehensive data collection was then undertaken in these individuals.
Results:
Within our service (n = 1574), 33 young people with T2DM were identified. Significant levels of co-morbidity were evident - dyslipidaemia (56%), microalbuminuria (45%), hypertension (30%) and abnormal retinal findings (25%). Hypertension was more likely in those with greater initial and follow-up body mass index (BMI) [mean (SD) BMI: 36.3 (5.0) vs. 28.0 (6.3) kg/m(2) , p = 0.001, and 36.8 (5.3) vs. 28.5 (7.8) kg/m(2) , p = 0.007, respectively] and BMI standard deviation score (SDS) [mean (SD) BMI SDS: 2.34 (0.30) vs. 1.72 (0.66), p = 0.001, and 2.26 (0.31) vs. 1.38 (0.87), p < 0.001, respectively], whereas abnormal retinal findings were seen in those with higher HbA1c values at last appointment [geometric mean (range) 10.9 (8.4-13.6) vs. 7.4 (5.6-12.5)%, p = 0.01) and those with greater increases in HbA1c over time (+4.1 (3.1) vs. +0.2 (1.9)%, p = 0.009). Of the 33,9 (27%) were lost to follow-up.
Conclusions:
At present, T2DM in youth remains a low burden on our services. Patients with this diagnosis, however, have significant problems that present a major challenge to the development of effective management strategies.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes I: Introduction
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type I Diabetes II: Pathophysiology
Type II Diabetes II: Pathophysiology